Antacids: study of potentiation, neutralization kinetics and financial cost
Leal, S.S.; Ribeiro, T.d.C.; Castro, L.d.P.
Amb Revista da Associacao Medica Brasileira 29(9-10): 149-154
1983
ISSN/ISBN: 0102-843X PMID: 6608759 Document Number: 208609
Document emailed within 1 workday
Related Documents
Monges, H.; Hancy, A.; Rouison, D.; Chabaud, M. 1971: Comparative study of the action of antacids on the gastric pH. in situ determination by telemetry (10 antacids, 200 tests) Archives Francaises des Maladies de l'Appareil Digestif 60(8): 482Chen, L-Wu.; Stoner, J.; Makhanu, C.; Minikus, K.; Mueller, K.J. 2004: An analysis of the agreement between financial data between the Medicare Cost Report and the audited hospital financial statement Rural Policy Brief 9(4 ): 1-8
Sklar, D.; Liang, M.H.; Porta, J. 1977: Antacids: cost, taste and buffering New England Journal of Medicine 296(17): 1007
Koshy, A.; Naik, S.R.; Broor, S.L. 1981: Variability in in vitro neutralising capacity and cost efficiency ratio of liquid antacids Indian Journal of Medical Research 73: 126-129
Diotti, R.A.; Sautto, G.A.; Solforosi, L.; Mancini, N.; Clementi, M.; Burioni, R. 2012: Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein New Microbiologica 35(4): 475-479
Amoo, G.; Ogunlesi, A.O. 2005: Financial cost of treating Nigerian in-patients with schizophrenia African Journal of Medicine and Medical Sciences 34(1): 15-23
LaBrake, K.J.; Pokrandt, H.S. 2010: Using the medicare cost report to improve financial performance Healthcare Financial Management: Journal of the Healthcare Financial Management Association 64(10): 72-78
Tympner, F. 1985: Evidence of the cytoprotective action of antacids. Behavior of the transmural stomach electric potential difference with antacids in healthy subjects and stomach ulcer patients Fortschritte der Medizin 103(33): 795-798
Jensen, E.R. 1991: Cost-effectiveness and financial sustainability in family planning operations research Progress in Clinical and Biological Research 371: 297-313
Herman, B.; Wolff, M.A.; Pean, Y.; Gertner, J.; Millet, H. 1985: Risks of infection related to venous catheterization and an attempt at estimating its financial cost Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 26(2): 197-202
Morales, M.M.; Llopis, A.; Sáiz, E. 1989: Epidemiologic aspects and financial cost of tuberculosis at the Clinical Hospital of Valencia from 1986 to 1987 Enfermedades Infecciosas y Microbiologia Clinica 7(1): 29-35
Sebestyén, A.; Boncz, I.; Dózsa, C.; Nyárády, József. 2004: Cost analysis of peritrochanteric fractures according to types of surgical treatment and progressive care from the viewpoint of financial providers Orvosi Hetilap 145(21): 1115-1121
1993: New study results with lattice-layered antacids Der Internist 34(11 Suppl): 1-12
Kapralov, N.V.; Sholomitskaia, I.A.; Grinshpan, D.D.; Nevar, T.N.; Savitskaia, T.A.; Boĭko, A.V. 2008: Study of acid neutralizing efficacy of antacids in vitro Eksperimental'naia i Klinicheskaia Gastroenterologiia 3: 44-48
Hagos, B.; Nganga, J.N.; Juma, F.D.; Ndegwa, P. 1989: A comparative study of the neutralising capacity of eight brands of antacids East African Medical Journal 66(6): 408-410
Pinilla, J.; Shafran, S.; Conly, J. 1992: A utilization and cost-benefit analysis of an aminoglycoside kinetics monitoring service Clinical and Investigative Medicine. Medecine Clinique et Experimentale 15(1): 8-17
Krug, M.; Bergado, J.; Ruethrich, H. 1990: Long-term potentiation and postconditioning potentiation--the same mechanism? Biomedica Biochimica Acta 49(4): 273-279
Zhong, Y.; Wu, X. 2020: Effects of cost-benefit analysis under back propagation neural network on financial benefit evaluation of investment projects Plos one 15(3): E0229739
Anderson, D.J.; Shelton, W. 2005: Clarify your financial picture with staff management tools. Consistent use of technology is critical to labor cost management and employee satisfaction Journal of Nursing Administration Suppl: 23-24
Doutremepuich, C.; Bonini, F.; de Seze, O.; Toulemonde, F.; Bayrou, B. 1986: Neutralization of a very low molecular weight heparin fraction CY 222 by protamine. in vitro and in vivo study Therapie 41(6): 433-436